Matthew B. Schabath, PhD, Moffitt Cancer Center, Tampa, FL

Individuals in the LGBTQI community face many barriers in accessing healthcare. In this episode, Dr. Matthew Schabath from the Moffitt Cancer Center addresses ways healthcare professionals can be more competent in supporting persons within this community. Dr. Schabath breaks down the terminology and stakeholders within this group to help make conversations comfortable and more productive with patients and their caregivers, discusses an overview of COLORS training and its importance, and describes how best to include caregivers and loved ones in patient care. Join this important conversation today!

Associate Member in Cancer Epidemiology

Moffitt Cancer Center

Tampa, FL

Matthew B. Schabath, PhD, Moffitt Cancer Center, Tampa, FL

Recorded on November 2, 2020

Individuals in the LGBTQI community face many barriers in accessing healthcare. In this episode, Dr. Matthew Schabath from the Moffitt Cancer Center addresses ways healthcare professionals can be more competent in supporting persons within this community. Dr. Schabath breaks down the terminology and stakeholders within this group to help make conversations comfortable and more productive with patients and their caregivers, discusses an overview of COLORS training and its importance, and describes how best to include caregivers and loved ones in patient care. Join this important conversation today!

Matthew B. Schabath, PhD

Associate Member in Cancer Epidemiology

Moffitt Cancer Center

Tampa, FL

Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY

Minimal/measurable residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. In this episode, Gail Roboz, MD, from Weill Cornell Medical College, provides an overview of MRD, including understanding its definition, explains the role advancements in technology have played in detection, and underscores the importance of understanding to what degree this detection can be helpful. Dr. Roboz provides strategies to communicate with patients about the impact of MRD on prognosis, treatment and outcomes and discusses the future of MRD testing in blood cancers. Tune in today!

Director, Clinical and Translational Leukemia Programs

Professor of Medicine

Weill Cornell Medical College

The New York Presbyterian Hospital
New York, NY

Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY

Recorded on October 2, 2020

Minimal/measurable residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. In this episode, Gail Roboz, MD, from Weill Cornell Medical College, provides an overview of MRD, including understanding its definition, explains the role advancements in technology have played in detection, and underscores the importance of understanding to what degree this detection can be helpful. Dr. Roboz provides strategies to communicate with patients about the impact of MRD on prognosis, treatment and outcomes and discusses the future of MRD testing in blood cancers. Tune in today!

Gail J. Roboz, MD

Director, Clinical and Translational Leukemia Programs

Professor of Medicine

Weill Cornell Medical College

The New York Presbyterian Hospital New York, NY

This podcast episode is supported by Amgen.

Allison J. Applebaum, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY

Caregivers of patients diagnosed with cancer often don’t allow themselves to connect to the negative emotions that arise. Discussion with Dr. Allison Applebaum focuses on the importance of coaching caregivers to ask for help, problem solve, formulate questions to ask the oncologist, have potentially challenging conversations with their loved one, and to receive professional and peer support. As Dr. Applebaum states, the simplest and most powerful intervention a healthcare professional can do is to ask the caregiver, whether in person or via telehealth, “How are you doing and what can I do to support you?” Tune in for strategies and an interesting discussion.

Assistant Attending Psychologist

Director, Caregivers Clinic

Department of Psychiatry & Behavioral Sciences

Memorial Sloan Kettering Cancer Center
New York, NY

Allison J. Applebaum, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY

Recorded on June 26, 2020

Caregivers of patients diagnosed with cancer often don’t allow themselves to connect to the negative emotions that arise. Discussion with Dr. Allison Applebaum focuses on the importance of coaching caregivers to ask for help, problem solve, formulate questions to ask the oncologist, have potentially challenging conversations with their loved one, and to receive professional and peer support. As Dr. Applebaum states, the simplest and most powerful intervention a healthcare professional can do is to ask the caregiver, whether in person or via telehealth, “How are you doing and what can I do to support you?” Tune in for strategies and an interesting discussion.

Allison J. Applebaum, Ph.D.

Assistant Attending Psychologist

Director, Caregivers Clinic

Department of Psychiatry & Behavioral Sciences

Memorial Sloan Kettering Cancer Center New York, NY

Carma Bylund, PhD, FACH, and Carla Fisher, PhD

Young adults (YAs) are navigating physical, cognitive, and psychological changes, and transitioning into a more independent time of their life including social life and making more decisions on their own. They often grapple with unique issues when faced with a cancer diagnosis. Carma Bylund, PhD, FACH and Carla Fisher, PhD discuss how best to communicate with these young adults. They describe techniques and tips for caregivers and HCPs (e.g. PACES model), and discuss topics such as fertility, intimacy, sexuality, LGBTQ specific needs, and how to encourage YAs to be involved in the decision making process for their care.

Carma Bylund, PhD, FACH
Professor
College of Journalism and Communications
College of Medicine
UF Health Cancer Center, University of Florida
Gainesville, FL

Carla Fisher, PhD
Associate Professor
College of Journalism and Communications
UF Health Cancer Center, University of Florida
Gainesville, FL

Carma Bylund, PhD, FACH, and Carla Fisher, PhD

Recorded on August 13, 2020

Young adults (YAs) are navigating physical, cognitive, and psychological changes, and transitioning into a more independent time of their life including social life and making more decisions on their own. They often grapple with unique issues when faced with a cancer diagnosis. Carma Bylund, PhD, FACH and Carla Fisher, PhD discuss how best to communicate with these young adults. They describe techniques and tips for caregivers and HCPs (e.g. PACES model), and discuss topics such as fertility, intimacy, sexuality, LGBTQ specific needs, and how to encourage YAs to be involved in the decision making process for their care.

Carma Bylund, PhD, FACHProfessorCollege of Journalism and CommunicationsCollege of MedicineUF Health Cancer Center, University of FloridaGainesville, FL

Carla Fisher, PhDAssociate ProfessorCollege of Journalism and CommunicationsUF Health Cancer Center, University of FloridaGainesville, FL

Nicole Gutman, MS, and Mary Kay Irwin, EdD

Children, adolescents, and young adults (AYAs) face unique challenges when returning to school during or after cancer treatment. In this episode, Nicole Gutman, MS, a School Intervention Consultant, and Mary Kay Irwin, EdD, Director of School Health, at Nationwide Children’s Hospital, describe the psychosocial, educational, and cognitive effects cancer has on a child/AYA, their parents, siblings, and classmates. They discuss age appropriate interventions to assist families, address strategies to help meet the students’ needs, review laws that protect pediatric cancer survivors’ rights, and identify resources to support families and school personnel.

Nicole Gutman, MS
School Intervention Consultant

Mary Kay Irwin, EdD
Director of School Health
Nationwide Children’s Hospital

Nicole Gutman, MS, and Mary Kay Irwin, EdD

Recorded on May 19, 2020

Children, adolescents, and young adults (AYAs) face unique challenges when returning to school during or after cancer treatment. In this episode, Nicole Gutman, MS, a School Intervention Consultant, and Mary Kay Irwin, EdD, Director of School Health, at Nationwide Children’s Hospital, describe the psychosocial, educational, and cognitive effects cancer has on a child/AYA, their parents, siblings, and classmates. They discuss age appropriate interventions to assist families, address strategies to help meet the students’ needs, review laws that protect pediatric cancer survivors’ rights, and identify resources to support families and school personnel.

Nicole Gutman, MSSchool Intervention Consultant

Mary Kay Irwin, EdDDirector of School HealthNationwide Children’s Hospital